CINECA IRIS Institutional Research Information System
IRIS è l'Anagrafe della ricerca dell'Università degli Studi di Trento, e ha lo scopo di raccogliere, documentare, conservare e diffondere, anche ad accesso aperto, la produzione scientifica degli autori afferenti all'Università degli Studi di Trento.
EnglishThe ability to adapt to environmental stress, including therapeutic insult, contributes to tumor evolution and drug resistance. In suboptimal conditions, the integrated stress response (ISR) promotes survival by dampening cytosolic translation. We show that ISR-dependent survival also relies on a concomitant up-regulation of mitochondrial protein synthesis, a vulnerability that can be exploited using mitoribosome-targeting antibiotics. Accordingly, such agents sensitized to MAPK inhibition, thus preventing the development of resistance in BRAFV600E melanoma models. Additionally, this treatment compromised the growth of melanomas that exhibited elevated ISR activity and resistance to both immunotherapy and targeted therapy. In keeping with this, pharmacological inactivation of ISR, or silencing of ATF4, rescued the antitumoral response to the tetracyclines. Moreover, a melanoma patient exposed to doxycycline experienced complete and long-lasting response of a treatment-resistant lesion. Our study indicates that the repurposing of mitoribosome-targeting antibiotics offers a rational salvage strategy for targeted therapy in BRAF mutant melanoma and a therapeutic option for NRAS-driven and immunotherapy-resistant tumors.
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma / Vendramin, R.; Katopodi, V.; Cinque, S.; Konnova, A.; Knezevic, Z.; Adnane, S.; Verheyden, Y.; Karras, P.; Demesmaeker, E.; Bosisio, F. M.; Kucera, L.; Rozman, J.; Gladwyn-Ng, I.; Rizzotto, L.; Dassi, E.; Millevoi, S.; Bechter, O.; Marine, J. -C.; Leucci, E.. - In: JOURNAL OF EXPERIMENTAL MEDICINE. - ISSN 0022-1007. - 218:9(2021). [10.1084/jem.20210571]
Scheda prodotto non validato
I dati visualizzati non sono stati ancora sottoposti a validazione formale da parte dello Staff di IRIS, ma sono stati ugualmente trasmessi al Sito Docente Cineca (Loginmiur).
| Titolo: | Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma | |
| Autori: | Vendramin, R.; Katopodi, V.; Cinque, S.; Konnova, A.; Knezevic, Z.; Adnane, S.; Verheyden, Y.; Karras, P.; Demesmaeker, E.; Bosisio, F. M.; Kucera, L.; Rozman, J.; Gladwyn-Ng, I.; Rizzotto, L.; Dassi, E.; Millevoi, S.; Bechter, O.; Marine, J. -C.; Leucci, E. | |
| Autori Unitn: | ||
| Titolo del periodico: | JOURNAL OF EXPERIMENTAL MEDICINE | |
| Anno di pubblicazione: | 2021 | |
| Numero e parte del fascicolo: | 9 | |
| Codice identificativo Scopus: | 2-s2.0-85111477752 | |
| Codice identificativo Pubmed: | 34287642 | |
| Codice identificativo WOS: | WOS:000704364600005 | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1084/jem.20210571 | |
| Handle: | http://hdl.handle.net/11572/332316 | |
| Citazione: | Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma / Vendramin, R.; Katopodi, V.; Cinque, S.; Konnova, A.; Knezevic, Z.; Adnane, S.; Verheyden, Y.; Karras, P.; Demesmaeker, E.; Bosisio, F. M.; Kucera, L.; Rozman, J.; Gladwyn-Ng, I.; Rizzotto, L.; Dassi, E.; Millevoi, S.; Bechter, O.; Marine, J. -C.; Leucci, E.. - In: JOURNAL OF EXPERIMENTAL MEDICINE. - ISSN 0022-1007. - 218:9(2021). [10.1084/jem.20210571] | |
| Appare nelle tipologie: |
File in questo prodotto:
Copyright © 2022